Skip to main content
Log in

Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer’s dementia

  • Review Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

The term “cardiogenic dementia” was introduced a few decades ago to indicate an alteration of consciousness and cognition due to heart disease. Although this term is now disused, the relationship between cardiovascular disease and cognitive impairment is currently of great interest, not only for its potential therapeutic implications, but also for the recently recognized important role that vascular factors appear to play in Alzheimer’s disease. The aims of this review are therefore 1) to show data supporting the role of cardiac disease — namely congestive heart failure, myocardial infarction and atrial fibrillation — and other vascular risk factors — i.e., hypertension and diabetes — in the development or worsening of cognitive impairment; 2) to highlight recent observations on the relationship between presence and severity of congestive heart failure / myocardial infarction / atrial fibrillation and Alzheimer’s disease; and 3) to uncover the type of studies needed in this field in order to facilitate a more precise algorithm of dementia prevention as well as intervention in demented patients with cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hodkinson H.M.: Common symptoms of disease in the elderly. Blackwell Scientific Publications, Oxford, 1976.

    Google Scholar 

  2. Livesley B.: Action and ageing. Proceedings of Sandoz Symposium, Basle, 1976.

    Google Scholar 

  3. Editorial: Cardiogenic dementia. Lancet 1: 27–28, 1977.

  4. Rockwood K.: Acute confusion in elderly medical patients. J. Am. Geriatr. Soc. 37: 150–154, 1989.

    CAS  PubMed  Google Scholar 

  5. Rosenberg G.A., Haaland K.Y.: Cardiogenic dementia. Lancet 2: 1171, 1981.

    Google Scholar 

  6. Bennett D.A.: Diabetes and change in cognitive function. Arch. Intern. Med. 160: 141–143, 2000.

    Article  CAS  PubMed  Google Scholar 

  7. Hèbert R., Lindsay J., Verreault R., Rockwood K., Hill G., Dubois M.F.: Vascular dementia. Incidence and risk factors in the Canadian Study of Health and Aging. Stroke 31: 1487–1493, 2000.

    Article  PubMed  Google Scholar 

  8. Kilander L., Nyman H., Hansson L., Boberg M., Lithell H.: Hypertension and associated metabolic disturbances are related to cognitive impairment. A 20-year follow-up of 999 men. Hypertension 31: 780–786, 1998.

    Article  CAS  PubMed  Google Scholar 

  9. Folstein M.F., Folstein S.E., McHugh P.R.: “Mini Mental State”: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12: 189–198, 1975.

    Article  CAS  PubMed  Google Scholar 

  10. Lezak M.: Neuropsychological Assessment. ed. 3. New York, Oxford University Press, 1995.

    Google Scholar 

  11. Wechsler D.: Wechsler Adult Intelligence Scale, revised. The Psychological Corporation, San Antonio, CA, 1981.

    Google Scholar 

  12. Kaplan E., Fein D., Morris R., Delis D.C.: WAIS-R NI. The Psychological Corporation, San Antonio, CA, 1991.

    Google Scholar 

  13. Elias M.F., Wolf P.A., D’Agostino R.B.: Untreated blood pressure level is inversely related to cognitive functioning. The Framingham Study. Am. J. Epidemiol. 138: 353–364, 1993.

    CAS  PubMed  Google Scholar 

  14. Pierce T.W., Elias M.F.: Cognitive function and cardiovascular responsivity in subjects with a parental history of hypertension. J. Behav. Med. 16: 277–294, 1993.

    Article  CAS  PubMed  Google Scholar 

  15. Tzourio C., Dufouil C., Ducimetiere P., Alpèrovitch A., for the EVA Study Group: Cognitive decline in individuals with high blood pressure. Neurology 53: 1948–1952, 1999.

    Article  CAS  PubMed  Google Scholar 

  16. Tzourio C., Anderson C.: Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee. J. Hypertens. (Suppl. 18): S21–S24, 2000.

    CAS  Google Scholar 

  17. Gregg E.W., Yaffe K., Cauley J.A., Rolka D.B., Blackwell T.L., Narayan K.M.V., Cummings S.R., for the Study of Osteo-porotic Fractures Research Group: Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch. Intern. Med. 160: 174–180, 2000.

    Article  CAS  PubMed  Google Scholar 

  18. Hoyer S.: Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp. Gerontol. 35: 1363–1372, 2000.

    Article  CAS  PubMed  Google Scholar 

  19. Skoog I.: Vascular aspects in Alzheimer’s disease. J. Neural Transm. (Suppl. 59): 37–43, 2000.

    CAS  Google Scholar 

  20. Kalaria R.N.: The role of cerebral ischemia in Alzheimer’s disease. Neurobiol. Aging 21: 321–330, 2000.

    Article  CAS  PubMed  Google Scholar 

  21. Ryan C.M., Geckle M.: Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab. Res. Rev. 16: 308–315, 2000.

    Article  CAS  PubMed  Google Scholar 

  22. Bent N., Rabbitt P., Metcalfe D.: Diabetes mellitus and the rate of cognitive ageing. Br. J. Clin. Psychol. 39: 349–362, 2000.

    Article  PubMed  Google Scholar 

  23. Sinclair A.J., Girling A.J., Bayer A.J.: Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. Diabetes Res. Clin. Pract. 50: 203–212, 2000.

    Article  CAS  PubMed  Google Scholar 

  24. Kilander L., Andrèn B., Nyman H., Lind L., Boberg M., Lithell H.: Atrial fibrillation is an independent determinant of low cognitive function. A cross-sectional study in elderly men. Stroke 29: 1816–1820, 1998.

    Article  CAS  PubMed  Google Scholar 

  25. Furberg C.D., Psaty B.M., Manolio T.A.: Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am. J. Cardiol. 74: 236–241, 1994.

    Article  CAS  PubMed  Google Scholar 

  26. Farina E., Magni E., Ambrosini F., Manfredini R., Binda A., Sina C., Mariani C.: Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol. Scand. 96: 310–316, 1997.

    Article  CAS  PubMed  Google Scholar 

  27. Sabatini T., Frisoni G.B., Barbisoni P., Bellelli G., Rozzini R., Trabucchi M.: Atrial fibrillation and cognitive disorders in older people. J. Am. Geriatr. Soc. 48: 387–390, 2000.

    CAS  PubMed  Google Scholar 

  28. Zito M., Muscari A., Marini E., Di Iorio A., Puddu G.M., Abate G.: Silent lacunar infarcts in elderly patients with chronic non valvular atrial fibrillation. Aging Clin. Exp. Res. 8: 341–346, 1996.

    Article  CAS  Google Scholar 

  29. de Leeuw F.E., de Groot J.C., Oudkerk M., Kors J.A., Hof-man A., van Gijn J., Breteler M.M.B.: Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 54: 1795–1800, 2000.

    Article  PubMed  Google Scholar 

  30. Rengo F., Acanfora D., Trojano L., Scognamiglio P., Ciaburri F., Ceriello A., Bollella O.F., Lanzillo T., Papa A.: Congestive heart failure and cognitive impairment in the elderly. Arch. Gerontol. Geriatr. 20: 63–68, 1995.

    Article  CAS  PubMed  Google Scholar 

  31. Acanfora A.D., Trojano L., Iannuzzi G.L., Furgi G., Picone C., Rengo C., Abete P., Rengo F. for the CHF Italian Study Investigators: The brain in congestive heart failure. Arch. Gerontol. Geriatr. 23: 247–256, 1996.

    Article  CAS  PubMed  Google Scholar 

  32. Cacciatore F., Abete P., Ferrara N., Calabrese C., Napoli C., Maggi S., Varricchio M., Rengo F., for the Osservatorio Geriatrico Campano Study Group: Congestive heart failure and cognitive impairment in an older population. J. Am. Geriatr. Soc. 46: 1343–1348, 1998.

    CAS  PubMed  Google Scholar 

  33. Zuccalà G., Cattel C., Manes-Gravina E., Di Niro M.G., Coc-chi A., Bernabei R.: Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J. Neu-rol. Neurosurg. Psychiatry 63: 509–512, 1997.

    Article  Google Scholar 

  34. Bornstein R.A., Starling R.C., Myerowitz P., Haas G.J.: Neu-ropsychological function in patients with end-stage heart failure before and after cardiac transplantation. Acta Neurol. Scand. 91: 260–265, 1995.

    Article  CAS  PubMed  Google Scholar 

  35. Schall R.R., Petrucci R.J., Brozena S.C., Cavarocchi N.C., Jes-sup M.: Cognitive function in patients with symptomatic dilated cardiomyopathy before and after cardiac transplantation. J. Am. Coll. Cardiol. 14: 1666–1672, 1989.

    Article  CAS  PubMed  Google Scholar 

  36. Breteler M.M.B., Claus J.J., Grobbee D.E., Hofman A.: Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 308: 1604–1608, 1994.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Legault S.E., Joffe R.T., Armstrong P.W.: Psychiatric morbidity during the early phase of coronary care for myocardial infarction: association with cardiac diagnosis and outcome. Can. J. Psychiatry 37: 316–325, 1992.

    CAS  PubMed  Google Scholar 

  38. Ahto M., Isoaho I., Puolijoki H., Laippala P., Sulkava R., Kivelä S.L.: Cognitive impairment among elderly coronary heart disease patients. Gerontology 45: 87–95, 1999.

    Article  CAS  PubMed  Google Scholar 

  39. Grubb N.R., O’Carroll R.E., Cobbe S.M., Sirel J., Fox K.A.A.: Chronic memory impairment after cardiac arrest outside hospital. BMJ 313: 143–146, 1996.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Grubb N.R., Fox K.A.A., Smith K., Best J., Blane A., Ebmeier K.P., Glabus M.F., O’Carroll R.E.: Memory impairment in out-of-hospital cardiac arrest survivors is associated with global reduction in brain volume, not focal hippocampal injury. Stroke 31: 1509–1514, 2000.

    Article  CAS  PubMed  Google Scholar 

  41. Cervilla J.A., Prince M., Mann A.: Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J. Neurol. Neurosurg. Psychiatry 68: 622–626, 2000.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Nordberg M., Winblad B., Fratiglioni L., Basun H.: Lead concentrations in elderly urban people related to blood pressure and mental performance: results from a population study. Am. J. Ind. Med. 38: 290–294, 2000.

    Article  CAS  PubMed  Google Scholar 

  43. Knopman D., Boland L.L., Mosley T., Howard G., Liao D., Szklo M., McGovern P., Folsom A.R. for the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56: 42–48, 2001.

    Article  CAS  PubMed  Google Scholar 

  44. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., Persson G., Odèn A., Svanborg A.: 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141–1145, 1996.

    Article  CAS  PubMed  Google Scholar 

  45. Skoog I., Palmertz B, Andreasson L.A.: The prevalence of white matter lesions on computed tomography of the brain in demented and non-demented 85-year olds. J. Geriatr. Psychiatry Neurol. 7: 169–175, 1994.

    Article  CAS  PubMed  Google Scholar 

  46. Forette F., Seux M.L., Staessen J.A., Thijs L., Birkenhäger W.H., Babarskiene M.R., Babeanu S., Bossini A., Gil-Ex-tremera G., Girerd X., Laks T., Lilov E., Moisseyev V., Tuomilehto J., Vanhanen H., Webster J., Yodfat Y., Fagard R., on behalf of the Syst-Eur Investigators: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352: 1347–1351, 1998.

    Article  CAS  PubMed  Google Scholar 

  47. Launer L.J., Ross G.W., Petrovitch H., Masaki K., Foley D., White L.R., Havlik R.J.: Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol. Aging 21: 49–55, 2000.

    Article  CAS  PubMed  Google Scholar 

  48. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., Breteler M.M.B.: Association of diabetes mellitus and dementia: The Rotterdam Study: Diabetologia 39: 1392–1397, 1996.

    Article  CAS  PubMed  Google Scholar 

  49. Ott A., Breteler M.M.B., de Bruyne M.C., van Harskamp F., Grobbee D.E., Hofman A.: Atrial fibrillation and dementia in a population-based study. The Rotterdam Study: Stroke 28: 316–321, 1997.

    Article  CAS  PubMed  Google Scholar 

  50. Aronson M.K., Ooi W.L., Morgenstern H., Hafner A., Masur D., Crystal H., Frishman W.H., Fisher D., Katzman R.: Women, myocardial infarction, and dementia in the very old. Neurology 40: 1102–1106, 1990.

    Article  CAS  PubMed  Google Scholar 

  51. Sparks D.L., Hunsaker J.C. III, Scheff S.W., Kryscio R.J., Henson J.L., Markesbery W.R.: Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease. Neu-robiol. Aging 11: 601–607, 1990.

    Article  CAS  Google Scholar 

  52. Loscalzo J.: The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98: 5–7, 1996.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Bots M.L., Launer L.J., Lindemans J., Hofman A., Grobbee D.E.: Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study. J. Intern. Med. 242: 339–347, 1997.

    Article  CAS  PubMed  Google Scholar 

  54. Kalmijn S., Launer L.J., Lindemans J., Bots M.L., Hofman A., Breteler M.M.B.: Total homocysteine and cognitive decline in a community-based sample of elderly subjects. The Rotterdam Study. Am. J. Epidemiol. 150: 283–289, 1999.

    Article  CAS  PubMed  Google Scholar 

  55. Polidori M.C., Mecocci P., Cecchetti R., Cherubini A., Senin U.: Plasma homocysteine and vitamin status in very old patients with vascular and Alzheimer dementia. Proceedings of the First International Congress on Vascular Dementia, Geneva, October 3-6, 1999 (Abstract).

    Google Scholar 

  56. Van der Cammen T.J.M., Vershoor C.J., Van Loon C.P.M.: Risk of left ventricular dysfunction in patients with probable Alzheimer’s disease with APOE4 allele. J. Am. Geriatr. Soc. 46: 962–967, 1998.

    PubMed  Google Scholar 

  57. Sagnella G.A., Rothwell M.J., Onipinla A.K., Wicks P.D., Cook D.G., Cappuccio F.P.: A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J. Hypertens. 17: 657–664, 1999.

    Article  CAS  PubMed  Google Scholar 

  58. Skoog I., Nilsson L., Palmertz B., Andreasson L., Svanborg A.: A population-based study of dementia in 85-year olds. N. En-gl. J. Med. 328: 153–158, 1993.

    Article  CAS  Google Scholar 

  59. Larson E.B.: Illnesses causing dementia in the very elderly. N. Engl. J. Med. 328: 203–205, 1993.

    Article  CAS  PubMed  Google Scholar 

  60. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R.: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813–817, 1997.

    Article  CAS  PubMed  Google Scholar 

  61. Heyman A., Fillenbaum G.G., Welsh-Bomer K.A., Gearing M., Mirra S.S., Mohs R.C., Peterson B.L., Pieper C.F.: Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease. CERAD, part XVIII. Neurology 51: 159–162, 1998.

    Article  CAS  PubMed  Google Scholar 

  62. Nagata K., Kondoh Y., Atchison R., Sato M., Satoh Y., Watahi-ki Y., Hirata Y., Yokoyama E.: Vascular and metabolic reserve in Alzheimer’s disease. Nuerobiol. Aging 21: 301–307, 2000.

    Article  CAS  Google Scholar 

  63. Kudo T., Imaizumi K., Tanimukai H., Katayama T., Sato N., Nakamura Y., Tanaka T., Kashiwagi Y., Jinno Y., To-hyama M., Takeda M.: Are cerebrovascular factors involved in Alzheimer’s disease? Neurobiol. Aging 21: 215–224, 2000.

    Article  CAS  PubMed  Google Scholar 

  64. Farkas E., De Vos R.A.I., Steur E.N.H.J., Luiten P.G.M.: Are Alzheimer’s disease, hypertension, and cerebrocapillary damage related? Neurobiol. Aging 21: 235–243, 2000.

    Article  CAS  PubMed  Google Scholar 

  65. De la Torre J.C.: Critically attained threshold of cerebral hy-poperfusion: the CATCH hypothesis of Alzheimer’s patho-genesis. Neurobiol. Aging 21: 331–342, 2000.

    Article  PubMed  Google Scholar 

  66. Solerte S.B., Ceresini G., Ferrari E., Fioravanti M.: Hemorhe-ological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer’s type: adverse effects on cerebromicrovascular system. Neurobiol. Aging 21: 271–281, 2000.

    Article  CAS  PubMed  Google Scholar 

  67. Mecocci P., MacGarvey U., Kaufman A.E., Koontz D., Shoffn-er J.M., Wallace D.C., Beal M.F.: Oxidative damage to mi-tochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34: 609–616, 1993.

    Article  CAS  PubMed  Google Scholar 

  68. Polidori M.C., Mecocci P., Briviba K., Reimann A., Cec-chetti R., Stahl W., Sies H., Senin U.: Plasma lipid peroxidation and vitamin C status in healthy centenarians. J. Am. Geriatr. Soc. 47: 1038–1039, 1999 (Letter).

    CAS  PubMed  Google Scholar 

  69. Mecocci P., Polidori M.C., Troiano L., Cherubini A., Cecchetti R., Pini G., Straatman M., Monti D., Stahl W., Sies H., Franceschi C., Senin U.: Plasma antioxidants and longevity: a study on healthy centenarians. Free Rad. Biol. Med. 28: 1243–1248, 2000.

    Article  CAS  PubMed  Google Scholar 

  70. Polidori M.C., Frei B., Cherubini A., Nelles G., Rordorf G., Keaney J.F.K. Jr., Schawamm L., Mecocci P., Koroshetz W.J., Beal M.F.: Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Rad. Biol. Med. 25: 561–567, 1998.

    Article  CAS  PubMed  Google Scholar 

  71. Polidori M.C., Mecocci P., Stahl W., Parente B., Cecchetti R., Cherubini A., Cao P., Sies H., Senin U.: Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab. Res. Rev. 16: 15–19, 2000.

    Article  CAS  PubMed  Google Scholar 

  72. Polidori M.C., Mecocci P., Cecchetti R., Alunni G., Savino K., Corea L., Senin U.: Plasma antioxidant status in elderly subjects with congestive heart failure and type 2 diabetes. Proceedings of the IV European Congress of Gerontology, “Aging in Europe - European Aging”, Berlin, Germany, July 7–11, 1999. Zeitschrift fuer Gerontologie und Geriatrie, 32 S 2: 124, 1999 (Abstract).

    Google Scholar 

  73. Polidori M.C., Stahl W., Eichler O., Niestroj I., Sies H.: An-tioxidant profiles in human plasma. Free Rad. Biol. Med. 30: 456–462, 2001.

    Article  CAS  PubMed  Google Scholar 

  74. Cherubini A., Polidori M.C., Bregnocchi M., Pezzuto S., Cecchetti R., Ingegni T., Di Iorio A., Senin U., Mecocci P.: Plasma antioxidant profile and early outcome in elderly stroke patients. Stroke 31: 2295–2300, 2000.

    Article  CAS  PubMed  Google Scholar 

  75. Mecocci P., MacGarvey U., Beal M.F.: Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann. Neurol. 36: 747–751, 1994.

    Article  CAS  PubMed  Google Scholar 

  76. Mecocci P., Polidori M.C., Ingegni T., Cherubini A., Chionne F., Cecchetti R., Senin U.: Oxidative damage to DNA from AD patients. Neurology 51: 1014–1017, 1998.

    Article  CAS  PubMed  Google Scholar 

  77. Mecocci P., Polidori M.C., Mattioli P., Cecchetti R., Ingegni T., Cherubini A., Catani M., Senin U.: Plasma antioxidants and ox-idative DNA damage in lymphocytes from normal aged people and Alzheimer disease patients. Proceedings of the World Alzheimer Congress 2000, Washington D.C., July 9-18, 2000. Neurobiol. Aging 21 (Suppl. 1): 273, 2000 (Abstract).

    Article  Google Scholar 

  78. Butterfield D.A., Varadarajan S., Aksenova M., Link C., Yatin S.M.: On methionine and Alzheimer’s amyloid -peptide (1-42)-induced oxidative stress. Neurobiol. Aging 20: 339–342, 1999.

    Article  Google Scholar 

  79. Lin B., Schmidt-Kastner R., Busto R., Ginsberg M.D.: Progressive parenchymal deposition of -amyloid precursor protein in rat brain following global cerebral ischemia. Acta Neuropathol. 97: 359–368, 1999.

    Article  CAS  PubMed  Google Scholar 

  80. Misonou H., Morishima-Kawashima M., Ihara Y.: Oxidative stress induces intracellular accumulation of amyloid protein (Abeta) in human neuroblastoma cells. Biochemistry 39: 6951–6959, 2000.

    Article  CAS  PubMed  Google Scholar 

  81. Shi J., Yang S.H., Stubley L., Day A.L., Simpkins J.W.: Hypoperfusion induces over expression of -amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 853: 1–4, 2000.

    Article  CAS  PubMed  Google Scholar 

  82. Selhub J., Bagley L.C., Miller J., Rosenberg I.H.: B vitamins, homocysteine, and neurocognitive function in the elderly. Am. J. Clin. Nutr. 71: 614S–620S, 2000.

    CAS  PubMed  Google Scholar 

  83. Kukull W.A.: The association between smoking and Alzheimer’s disease: effects of study design and bias. Biol. Psychiatry 49: 194–199, 2001.

    Article  CAS  PubMed  Google Scholar 

  84. Mattson M.P.: Existing data suggest that Alzheimer’s disease is preventable. Ann. N.Y. Acad. Sci. 924: 153–159, 2000.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. C. Polidori M.D..

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Polidori, M.C., Marvardi, M., Cherubini, A. et al. Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer’s dementia. Aging Clin Exp Res 13, 231–239 (2001). https://doi.org/10.1007/BF03351481

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351481

Key words

Navigation